Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren’s syndrome by inducing regulatory T cells

References

• Mariette X, Criswell LA. Primary Sjögren’s syndrome. N Engl J Med. 2018;378(10):931–9.
   PubMed Web of Science ®Google Scholar
• Jonsson R, Brokstad KA, Jonsson MV, Delaleu N, Skarstein K. Current concepts on Sjögren’s syndrome - classification criteria and biomarkers. Eur J Oral Sci. 2018;126(S1):37–48.
   PubMedGoogle Scholar
• Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann Rheum Dis. 2017;76(7):1161–8.
   PubMed Web of Science ®Google Scholar
• Vivino F, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjögren’s syndrome: an update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81–121.
   PubMed Web of Science ®Google Scholar
• Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sjögren’s syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment. Int J Med Sci. 2017;14(3):191–200.
   PubMed Web of Science ®Google Scholar
• Barr JY, Wang X, Meyerholz DK, Lieberman SM. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren’s syndrome. Immunol Cell Biol. 2017;95(8):684–94.
   PubMed Web of Science ®Google Scholar
• Park YS, Gauna A, Cha S. Mouse models of primary Sjögren’s syndrome. Curr Pharm Des. 2015;21(18):2350–64.
   PubMed Web of Science ®Google Scholar
• Peck AB, Nguyen CQ. What can Sjögren’s syndrome-like disease in mice contribute to human Sjögren’s syndrome? Clin Immunol. 2017;182:14–23.
   PubMed Web of Science ®Google Scholar
• Saito M, Otsuka K, Ushio A, Yamada A, Arakaki R, Kudo Y. Unique phenotypes and functions of follicular helper T cell and regulatory T cell in Sjögren’s syndrome. Curr Rheumatol Rev. 2017;13(999):239–45.
   Google Scholar
• Miyara M, Ito Y, Sakaguchi S. TREG-cell therapies for autoimmune rheumatic diseases. Nat Rev Rheumatol. 2014;10(9):543–51.
   PubMed Web of Science ®Google Scholar
• Eltayeb AA, Sayed DM, Afifi NA, Ibrahim MA, Sheref TM. Regulatory T cell subsets in children with systemic lupus erythematosus. Clin Rheumatol. 2014;33(8):1085–91.
   PubMed Web of Science ®Google Scholar
• Kailashiya V, Singh U, Rana R, Singh NK, Dash D, Kailashiya J. Regulatory T cells and their association with serum markers and symptoms in systemic lupus erythematosus and rheumatoid arthritis. Immunol Invest. 2018;48:64–78.
   PubMed Web of Science ®Google Scholar
• Macdonald KG, Dawson NA, Huang Q, Dunne JV, Levings MK, Broady R. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis. J Allergy Clin Immunol. 2015;135(4):946–55.e9.
   PubMed Web of Science ®Google Scholar
• Göschl L, Scheinecker C, Bonelli M. Treg cells in autoimmunity: from identification to Treg-based therapies. Semin Immunopathol. 2019;41(3):301–14.
   PubMed Web of Science ®Google Scholar
• Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Mirabelli G, et al. T regulatory and T helper 17 cells in primary Sjögren’s syndrome: facts and perspectives. Mediators Inflamm. 2015;2015:1–10.
   Web of Science ®Google Scholar
• Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A. Mesenchymal stem cells: identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods. 2016;99:62–8.
   PubMed Web of Science ®Google Scholar
• Elahi KC, Klein G, Avci-Adali M, Sievert KD, Macneil S, Aicher WK. Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and sisplay distinct differentiation patterns. Stem Cells Int. 2015;2016(4):5646384.
   PubMedGoogle Scholar
• Andrzejewska A, Lukomska B, Janowski M. Concise review: mesenchymal stem cells: from roots to boost. Stem Cells. 2019;37(7):855–64.
   PubMed Web of Science ®Google Scholar
• Mortada I, Mortada R. Epigenetic changes in mesenchymal stem cells differentiation. Eur J Med Genet. 2017;61:114–18.
   Web of Science ®Google Scholar
• Benami E, Berrihaknin S, Miller A. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev. 2011;10(7):410–5.
   PubMed Web of Science ®Google Scholar
• Maogen C, Wenru S, Xiaohong L, Zhiyong G, Julie W, Qunzhou Z, et al. Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. Arthritis Rheum. 2014;65(5):1181–93.
   Google Scholar
• Eljawhari JJ, Elsherbiny YM, Jones EA, Mcgonagle D. Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. QJM Monthly J Assoc Phys. 2014;107(7):505–14.
   PubMed Web of Science ®Google Scholar
• Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol. 2009;183(2):993–1004.
   PubMed Web of Science ®Google Scholar
• Xu J, Wang D, Liu D, Fan Z, Zhang H, Liu O, et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood. 2012;120(15):3142–51.
   PubMed Web of Science ®Google Scholar
• Ruan GF, Zheng L, Huang JS, Huang WX, Gong BD, Fang XX, et al. Effect of mesenchymal stem cells on Sjögren-like mice and the microRNA expression profiles of splenic CD4+ T cells. Exp Ther Med. 2017;13(6):2828–38.
   PubMed Web of Science ®Google Scholar
• Park YJ, Koh J, Gauna AE, Chen S, Cha S. Identification of regulatory factors for mesenchymal stem cell-derived salivary epithelial cells in a co-culture system. PLoS One. 2014;9(11):e112158.
   PubMed Web of Science ®Google Scholar
• Sharpe PT. Dental mesenchymal stem cells. Development. 2016;143(13):2273–80.
   PubMed Web of Science ®Google Scholar
• Nagamura-Inoue T, He H. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World J Stem Cells. 2014;6(2):195–202.
   PubMedGoogle Scholar
• Alessia A, Pia M, Onelia B, Giuseppe B, Sara C, Teresa P. In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjögren's syndrome. Rheumatology. 2015;54(1):163–8.
   PubMed Web of Science ®Google Scholar
• Liu R, Su D, Zhou M, Feng X, Li X, Sun L. Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren's syndrome through the secretion of indoleamine 2,3-dioxygenase. Rheumatology. 2015;54(2):332–42.
   PubMed Web of Science ®Google Scholar
• Lingyun S, Dan W, Jun L, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010;62:2467–75.
   PubMedGoogle Scholar
• Goules AV, Tzioufas AG, Moutsopoulos HM. Classification criteria of Sjögren’s syndrome. J Autoimmun. 2014;48–49:42–5.
   PubMed Web of Science ®Google Scholar
• Delporte C, Bryla A, Perret J. Aquaporins in salivary glands: from basic research to clinical applications. Int J Mol Sci. 2016;17(2):166.
   Web of Science ®Google Scholar
• Hosoi K. Physiological role of aquaporin 5 in salivary glands. Pflugers Arch Eur J Physiol. 2016;468(4):519–39.
   PubMed Web of Science ®Google Scholar
• Gresz V, Horvath A, Gera I, Nielsen S, Zelles T. Immunolocalization of AQP5 in resting and stimulated normal labial glands and in Sjögren’s syndrome. Oral Dis. 2015;21(1):e114–e120.
   PubMed Web of Science ®Google Scholar
• Arakaki R, Eguchi H, Yamada A, Kudo Y, Iwasa A, Enkhmaa T, et al. Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren’s syndrome. PLos One. 2014;9(5):e98390.
   PubMed Web of Science ®Google Scholar
• Cagliani J, Grande D, Molmenti EP, Miller EJ, Rilo H. Immunomodulation by mesenchymal stromal cells and their clinical applications. J Stem Cell Regen Biol. 2017;3(2):1–26.
   Google Scholar
• Tripp NH, Tarn J, Natasari A, Gillespie C, Mitchell S, Hackett KL, et al. Fatigue in primary Sjögren’s syndrome is associated with lower levels of proinflammatory cytokines. Rmd Open. 2016;2(2):1–10.
   Web of Science ®Google Scholar
• Liuqing W, Liping X, Hui S, Jing L. Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients with primary Sjögren’s syndrome. J Investig Med. 2017;65(3):717–21.
   PubMed Web of Science ®Google Scholar
• Nicaise C, Weischelbaum L, Schandene L, Gangji V, Dehavay F, Bouchat J, et al. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögre’s syndrome and triggers the secretion of pro-inflammatory cytokines in vitro. Clin Exp Rheumatol. 2017;35(1):129–36.
   PubMed Web of Science ®Google Scholar
• Liu C, Guan Z, Zhao L, Song Y, Wang H. Elevated level of circulating CD4 + Helios + FoxP3+ cells in primary Sjögren’s syndrome patients. Mod Rheumatol. 2017;27(4):630–22.
   PubMed Web of Science ®Google Scholar
• Sudzius G, Mieliauskaite D, Siaurys A, Viliene R, Butrimiene I, Characiejus D, et al. Distribution of peripheral lymphocyte populations in primary Sjögren’s syndrome patients. J Immunol Res. 2015;2015:854706.
   PubMed Web of Science ®Google Scholar
• Sandhya P, Kurien BT, Danda D, Scofield RH. Update on pathogenesis of Sjögren’s syndrome. Curr Rheumatol Rev. 2016;13(999):5–22.
   Google Scholar
• Fajardo-Orduña GR, Mayani H, Montesinos JJ. Hematopoietic support capacity of mesenchymal stem cells: biology and clinical potential. Arch Med Res. 2015;46(8):589–96.
   PubMed Web of Science ®Google Scholar
• Fathollahi A, Gabalou NB, Aslani S. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder. Lupus. 2018;27:1053–1064.
   PubMed Web of Science ®Google Scholar
• Farinazzo A, Angiari S, Turano E, Bistaffa E, Dusi S, Ruggieri S, et al. Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis. Sci Rep. 2018;8(1):7473.
   PubMedGoogle Scholar
• Mantovani C, Raimondo S, Haneef MS, Geuna S, Terenghi G, Shawcross SG, et al. Morphological, molecular and functional differences of adult bone marrow- and adipose-derived stem cells isolated from rats of different ages. Exp Cell Res. 2012;318(16):2034–48.
   PubMed Web of Science ®Google Scholar
• Li Y, Wu Q, Wang Y, Li L, Bu H, Bao J. Senescence of mesenchymal stem cells (review). Int J Mol Med. 2017;39(4):775–82.
   PubMed Web of Science ®Google Scholar
• He J, Zhao J, Li Z. Mucosal administration of α-fodrin inhibits experimental Sjögren’s syndrome autoimmunity. Arthritis Res Ther. 2008;10(2):R44.
   PubMed Web of Science ®Google Scholar
• Pearson JA, Wong FS, Wen L. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun. 2016;66:76–88.
   PubMed Web of Science ®Google Scholar
• Peter H, Brigitte SN, Mingjing H, Kristen S, Hiang LC, Michael S. IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and foxo1. J Immunol. 2015;195(8):3665–74.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Mübeccel A. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest. 2014;124(11):4678–80.
   PubMed Web of Science ®Google Scholar